Drugs.com - Pharma Industry News

Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics

WEDNESDAY, May 21, 2025 -- For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite receiving optimal...

May 21, 2025 - 18:50
 0
Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
WEDNESDAY, May 21, 2025 -- For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite receiving optimal...
Read More

Tags:

Previous Article

Supernus casts Busy Philipps as ‘Ms. Represented’ in Qelbree campaign targeting ...

Next Article

PREVENT Risk Score Accurately IDs People With Coronary Artery Calcium

Related Posts

Similar Survival Seen With Simple Versus Radical Hysterectomy for Cervical Cancer

Similar Survival Seen With Simple Versus Radical Hyster...

May 21, 2025  0

Some Triple Negative Breast Cancers Might Be Avoided by Longer Breastfeeding

Some Triple Negative Breast Cancers Might Be Avoided by...

May 15, 2025  0

Mepolizumab Yields Lower Rate of Moderate/Severe Exacerbations in COPD

Mepolizumab Yields Lower Rate of Moderate/Severe Exacer...

May 12, 2025  0